VeriMomIst decursinol in der Schwangerschaft sicher?
No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
Related ingredients
Frequently asked questions
- Ist decursinol in der Schwangerschaft sicher?
- No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- Ist decursinol während des Stillens sicher?
- No data were found showing transfer into milk, human lactation exposure, or reproductive classification for decursinol. No regulatory (CIR/SCCS/harmonised CLP) guidance or clinical reports were identified to indicate a breastfeeding hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- Ist decursinol sicher für Babyhaut?
- No infant‑specific safety or dermal‑absorption studies were located. Adult topical cosmetic exposure literature/regulatory sources are absent; because decursinol is a small lipophilic coumarin derivative with measurable bioactivity and dermal use in research contexts, neonatal/infant skin exposure is conservatively assigned higher exposure (+1) due to immature barrier and higher surface‑area:weight; no evidence was found to increase hazard or mechanism scores for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19228635/?utm_source=openai))
- Wie bewertet VeriMom decursinol?
- VeriMom bewertet decursinol mit 87/100 (geringes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu decursinol?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu decursinol basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.